Overview

Provides insight into the epidemic of the 21st century: chronic disease A leader in the field of healthcare shares his experiences, insights, and solutions for issuing, currently hindering, or delaying the process of providing quality healthcare Explores the role of technology in revolutionizing healthcare and healing Builds compassion and understanding between healthcare practitioners, administrators, insurance agencies, and patients Identifies areas for improvement within the healthcare industry Creates hope for the future of healthcare as it demonstrates how the healthcare industry is advancing life-saving, economically feasible healthcare focused on managing chronic disease Serves as the contemporary guide to navigating the ever-changing field of healthcare Demonstrates how the use of technology within the healthcare industry will improve the quality of care delivered while simultaneously decreasing illness and extending patients' lives Counters increasing concern for the future of the healthcare industry and depicts the positive direction of the field, while providing solutions for the issues that are currently slowing progress Unifies healthcare practitioners, physicians, administrators, policymakers, and patients in the fight to overcome the epidemic of our time: chronic disease

Full Product Details

9781683505877

Table of Contents

Reviews

Author Information

Dr. Richard Milani serves as the Chief Clinical Transformation Officer, Vice-Chairman of the Department of Cardiology at Ochsner Health System and Professor of Medicine at Ochsner Clinical School – The University of Queensland School of Medicine in New Orleans, Louisiana. His background and research focus on population health with a special interest in chronic disease and medical informatics. He serves as the Medical Director of Innovation Ochsner (iO), a health innovation accelerator that is a subsidiary of the Ochsner Health System. He has authored over 500 medical publications and serves as a frequent lecturer for healthcare systems and Fortune 500 companies.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available